Position in AVXL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$156,650
-$2,760,713 QoQ
Shares Held
60,483
-82.2% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 179 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Derivatives in AVXL
reported options exposure · as of Dec 31, 2021CallValue
$1,734,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. AVXL ranks #294 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in AVXL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $156,650 | 60,483 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $2,917,363 | 340,019 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,231,535 | 207,778 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,936,800 | 340,986 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $159,575 | 37,814 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $108,086 | 21,235 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $244,406 | 26,252 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,738,944 | 723,503 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,018,654 | 248,297 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $674,013 | 78,648 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,718,432 | 833,524 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,098,757 | 203,368 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,615,532 | 261,292 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $600,449 | 34,628 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $1,734,000 | 100,000 | Call | Sole | 2022-02-14 | |
| 2021-09-30 | $2,286,094 | 127,359 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,262,408 | 98,968 | Shares | Sole | 2021-08-16 | |
| 2020-06-30 | $50,966 | 10,359 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $345,372 | 109,642 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||